Scorpius Holdings (fka NightHawk Biosciences) begins trading under SCPX after name change

Scorpius Holdings, Inc.

Name changed to Scorpius Holdings, effective Feb 6, 2024; ticker changes to SCPX.
No impact on share structure or shareholder rights; no action required.
Company shifts to pure-play large molecule CDMO, citing capacity shortage and positive customer feedback.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

Scorpius Holdings, Inc.: Company changed its name from NightHawk Biosciences, Inc. to Scorpius Holdings, Inc. via a Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation, effective February 6, 2024 (effective 2024-02-06).

Change: charter amendment
Effective: 2024-02-06

Exact text from the filing

On February 5, 2024, Scorpius Holdings, Inc. (previously known as NightHawk Biosciences, Inc. ) filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to its Third Amended and Restated Certificate of Incorporation, as amended, to effect as of February 6, 2024, a change of its name to Scorpius Holdings, Inc. (the “Name Change”).

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001079973-24-000175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.